Somaxon Pharmaceuticals (SOMX) jumps in post-trade after saying it had a productive meeting with...

|About: Somaxon Pharmaceuticals, Inc. (SOMX)|By:, SA News Editor

Somaxon Pharmaceuticals (SOMX) jumps in post-trade after saying it had a productive meeting with the FDA relating to the over-the-counter development program for its insomnia drug Silenor, developed jointly with Procter & Gamble (PG). SOMX +22.5% AH.